Fri, October 13, 2017
Thu, October 12, 2017
Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017

David Risinger Maintained (TEVA) at Sell with Decreased Target to $15 on, Oct 5th, 2017


//stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-15-on-oct-5th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Decreased Target from $16 to $15 on, Oct 5th, 2017.

David has made no other calls on TEVA in the last 4 months.



There are 10 other peers that have a rating on TEVA. Out of the 10 peers that are also analyzing TEVA, 7 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $21 on, Wednesday, October 4th, 2017
  • Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
  • Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
  • Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017


These are the ratings of the 3 analyists that currently disagree with David


  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
  • Vamil Divan of "JMP Securities" Maintained at Sell with Increased Target to $14 on, Wednesday, September 6th, 2017
  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017

Publication Contributing Sources